baber/WOPTO huggingface dataset:
Patent NZ-299806-A (NZ)
Title: Propeller having transmission units located between slots of inner driving unit and outer thrust unit with latter having blades and ribs between inner and outer shaft naves
Inventor: LIN YEUN-JUNN
IPC: B63H23/34
Filed: 1996-11-22
Abstract: A propeller 10 for an outboard engine comprises a hub 20 comprising an outer shaft nave 21, an inner shaft nave 22 having a first axial hole 23 coaxial with said outer shaft nave 21, and a plurality of ribs 25 (which may be plate like or arcuate(fig. 4)) located between the inner edge of the outer shaft nave 21 and the outer edge of the inner shaft nave 22. The first axial hole 23 is provided in the inner wall thereof with a plurality of first retaining slots 24. A driving unit 14, which in use is splined to the shaft 17, of an outboard motor, is received in the first axial hole 23 and is provided in the outer periphery thereof with a plurality of second retaining slots 43. Relatively weak (plastics or alloy), rectangular or circular (fig. 7), transmission units 16 are disposed between the inner shaft nave 22 and the driving unit 14 such that they are engaged with the first retaining slots 24 and the second retaining slots 43. The transmission units 16, are easily replaced and the number of transmission units can be selected according to the power to be transmitted.
Patent NZ-321385-A (NZ)
Title: Method for treating dysphagia with electrical stimulation
Inventor: FREED MARCY L
IPC: A61N1/36
Filed: 1996-10-25
Abstract: This invention is directed to a simple, non-invasive method and device for treating dysphagia and artificially promoting swallowing by electrical stimulus. In the present invention, a plurality of electrodes are selectively placed in electrical contact with tissue of a pharyngeal region of patient and a series of electrical pulses in electrical contact with each of the plurality of electrodes with a generator. The generator includes a pulse rate modulator for generating each of the electrical pulses having a frequency generally fixed at 80 hertz, a pulse width modulator for generating each pulse of the series of electrical pulses at a duration generally fixed at 300 microseconds, and a governor for regulating the electrical pulses such that at least one of current so as not to exceed 4.4 milliamps RMS or power so as not to exceed 9.6 MW RMS. The electrical pulses selectively stimulate muscles located proximate to the selectively placed electrodes to initiate swallowing.
Patent NZ-322352-A (NZ)
Title: Method of producing mailing envelopes having labels with decorative graphics
Inventor: BEAUDOIN JAMES S
IPC: G09F3/10
Filed: 1996-11-27
Abstract: A method of producing mailing pieces is claimed.  Pressure sensitive adhesive labels having postal indicia on them are used to produce mailing pieces, and allow production of distinctive mailing pieces at high speeds (e.g. 300-500 feet per minute).  The labels have "POSTAGE PAID", an indication of rate such "BULK RATE" or "FIRST CLASS MAIL", and an indication of permit authorization such as "PERMIT NO.".  The pressure sensitive adhesive of the label is adhered to an envelope or postcard at an upper right corner of an addressable face of the envelope or postcard.  The label may have the same size as (and simulate) a conventional postage stamp, and the indicia may overlie the decorative graphics, with the indicia and the decorative graphics sharply color contrasting.  The method comprises the steps of : a) moving the envelope or postcard in a predetermined path and imaging address information on the addressable face and b) immediately before or after the imaging while moving the envelope, tipping or blowing the label on the addressable face so that the label first face is adhered to the envelope or postcard upper right corner by the label permanent adhesive.
Patent NZ-332830-A (NZ)
Title: Creatine pyruvates, method for their production and their use in medicaments for weight control, body fat control, increasing muscle strength, the treatment of oxygen deficiency conditions and as free radical scavengers
Inventor: PISCHEL IVO
IPC: A23L33/20
Filed: 1997-12-18
Abstract: The disclosure relates to creatine pyruvates of the general formula (creatine)x(pyruvate)y(H2O)n, in which x = 1-100, y = 1-10 and n = 0-10. These creatine pyruvates can be produced by the relatively simple reaction of creatine with pyruvic acid. They can be used to increase stamina and strength in the field of sport, for weight and body fat reduction in health care, in the treatment of oxygen deficiency conditions (ischaemia), obesity and overweight, as a food supplement additive, and as a radical interceptor.
Patent NZ-332926-A (NZ)
Title: Immunogenic non-naturally occurring peptides and molecules based on somatostatin that modulate the activity of hormones or their receptors peptides, antibodies, vaccines and uses thereof
Inventor: GERRATY NORMAN L
IPC: A61K38/00
Filed: 1997-05-22
Abstract: This application relates to immunogenic, non-naturally occurring peptides and immunologically reactive molecules thereto which modulate the activity of hormones or the receptors therefor. These peptides are based on portions of somatostatin, somatostatin receptors and insulin-like growth factor binding protein. Methods of modulating hormonal activity in an animal and compositions therefor are also contemplated.
Patent NZ-500033-A (NZ)
Title: Hydrophilic eimeria polypeptides for use as coccidiosis vaccines
Inventor: SCHAPP T C
IPC: A61K39/17
Filed: 1998-01-01
Abstract: A derivative of acyl-piperazinyl-pyrimidine of formula (I) wherein: X is an oxygen or sulphur atom; R1 is an alkoxy or trifluoromethyl radical; R2 is an alkyl radical; saturated cycloalkyl; heterocycloalkyl optionally N-substituted; phenyl optionally substituted with 1, 2 or 3 identical or different substituents selected from fluorine, chlorine, bromine, amino, acetamido, nitro, methyl, trifluoromethyl and methoxy; arylalkyl consisting of an alkyl group substituted by a phenyl radical optionally substituted by 1, 2 or 3 of the aforementioned substituents; heteroaryl or fused heteroaromatic system optionally substituted by 1, 2 or 3 of the aforementioned substituents; and heteroarylalkyl consisting of an alkyl group substituted with a heteroaryl radical or fused heteroaromatic system optionally substituted by 1, 2 or 3 of the aforementioned substituents; and their physiologically acceptable salts. The compounds have sedative, anticonvulsant, analgesic, muscular relaxant, antitusigenic, ansiolytic, antipsicotic, antidepressant, anti-cerebral ischeamic, anti-migraine activity and are useful in the treatment of sleep disorders, neurodegenerative diseases, cognitive disorders, Alzheimer's disease, sleep-inducing or as general anaesthetic agents.
Patent NZ-500679-A (NZ)
Title: Polyphase transverse flux DC motor with rotor having permanent magnets and stator of two pieces interengaging to provide alternating claw poles
Inventor: CHRISTIAN JOHN WADE GIANNI
IPC: H02K21/12
Filed: 1999-10-26
Abstract: In order to simplify manufacture of a polyphase transverse flux DC motor first and second complementary stator pieces are designed with alternating claw poles. Magnetically permeable bridging cores are disposed about the stator axis proximate to the claw poles. These are located between the stator pieces to provide magnetic flux paths therebetween. At least one stator piece is provided in the regions of high reluctance between the bridging cores. Stator windings are disposed about each bridging core, each of which when supplied with an exciting current produce flux flow through the stator claw poles. Flux is thus provided in the air gap between stator and rotor adjacent the claw poles. Each winding or selected set of windings corresponds to a motor phase, each of which is electronically commutated, to provide a rotary flux.
Patent NZ-504242-A (NZ)
Title: Razor blade assembly with blade mounting portion having at-rest position other than "mid-way" position
Inventor: APPRILLE DOMENIC V
IPC: B26B21/22
Filed: 1997-03-04
Abstract: Disclosed is a razor blade assembly pivotally connected to a handle with an "at-rest" (neutral) position of the blade housing other than the "mid-way" position.  Resilient movement away from the neutral position is allowed during shaving.
Patent NZ-505392-A (NZ)
Title: Write protect system for IDE hard disk in gaming machine
Inventor: STOCKDALE JAMES
IPC: G06F21/00
Filed: 2000-06-22
Abstract: A gaming machine incorporates an IDE hard disk drive 11 together with a write protect system for the disk.  The write protect system includes an IDE command latch 14, and a timing circuit 16 for timing signals between the command latch and the disk 11. A comparator15, consisting of a fixed command array and a user command array is connected between the command latch and the timing circuit.  A control and status register 12 controls the write protection system.  If the comparator receives a command from the command latch corresponding to a command in the comparator command register, a fault condition is set.  This system can be used to prevent unauthorised access to the hard disk.
Patent NZ-505479-A (NZ)
Title: Implanter device for subcutaneous implants
Inventor: DAVIS CRAIG R
IPC: A61J1/00
Filed: 1998-12-15
Abstract: An implant insertion system comprising: a vial having an opening and a closure for closing the opening; an elongated implant secured within the vial, the implant having a longitudinal axis aligned with the opening of the vial; and an implanter having a handle and an elongated cannula extending from the handle for receiving the implant from the vial, the elongated cannula configured to be inserted into the vial through the opening to remove the implant from the vial.
Patent NZ-506912-A (NZ)
Title: Fungicidal 6-(2-halo-4-alkoxyphenyl)- triazolopyrimidines
Inventor: PFRENGLE WALDEMAR
IPC: A01N43/90
Filed: 1999-03-19
Abstract: A   compound  of  formula  (I)  that  show  selective fungicidal activity is disclosed, wherein: R1  is  a  straight  chain or branched  C1-C6  alkyl,  C2-C6 alkenyl or C1-C6 haloalkyl; R2 is a hydrogen atom; R1  and  R2  together  with  the interjacent  nitrogen  atom represent  a  heterocyclic ring with 5  or  6  carbon  atoms optionally substituted with one or two C1-C6 alkyl groups; R3  is C1-C6 alkyl, C3-C6 alkenyl, C3-C6 alkynyl, phenyl C1- C6  alkyl, C1-C4 alkoxy- C1-C4 alkyl, di- C1-C4 alkoxy-  C1- C4 alkyl, phenyl or C1-C4 haloalkyl group; L1 is hydrogen, fluorine or chlorine atom; L2 is fluorine or chlorine atom; and Hal is a halogen atom. These   compounds  may  be  processed  with  carriers,   and optionally an adjuvant, to produce fungicidal compositions.
Patent NZ-507564-A (NZ)
Title: 4-substituted carbazole or tetrahydrocarbazole derivatives
Inventor: MORIN JOHN MICHAEL
IPC: C07D209/88
Filed: 1999-04-16
Abstract: A tricyclic compound or a pharmaceutically acceptable racemate, solvate, tautomer, optical isomer, prodrug derivative or salt, thereof of formula I which are useful for inhibiting sPLA2 mediated release of fatty acids wherein: Z is cyclohexenyl, or phenyl; R20 is an optionally substituted alkyl, alkenyl, alkynyl, carbocyclic or heterocyclic radical or -(L)-R80; -(L)- is a divalent linking group of 1 to 12 atoms selected from carbon, hydrogen, oxygen, nitrogen, and sulphur; wherein the combination of atoms in -(L)- are selected from the group consisting of (i) carbon and hydrogen only, (ii) one sulphur only, (iii) one oxygen only, (iv) one or two nitrogen and hydrogen only, (v) carbon, hydrogen, and one sulphur only, and (vi) an carbon, hydrogen, and oxygen only; R80 is a an optionally substituted alkyl, alkenyl, alkynyl, carbocyclic or heterocyclic radical; R21 is a non-interfering substituent; f is 1-3; R1 is -NHNH2, -NH2, or -CONH2; R2' is -OH, or -O(CH2)tR5' R5' is H, -CN, -NH2, -CONH2, -CONR9R10, -NHSO2R15, -CONHSO2R15, optionally substituted phenyl or -(La)-(acidic group); R9 and R10 are independently H, alkyl, phenyl, alkylphenyl or phenylalkyl or -CF3; R15 is alkyl or -CF3; (La)- is an acid linker having an acid linker length of 1 to 7; t is 1-5; R3' is non-interfering substituent, optionally substituted carbocyclic radicals or heterocyclic radicals limited by the provisos of the specification.
Patent NZ-508133-A (NZ)
Title: Anti-diarrheal and method for using the same
Inventor: GREENBLATT HELLEN CHAYA
IPC: A61K35/54
Filed: 1999-05-07
Abstract: Disclosed are a food product and method for treating and preventing diarrhea in a subject animal suffering from or susceptible to diarrhea. The method comprises administering a hyperimmunised egg product to the subject animal wherein the egg product is obtained from a hyperimmunized avian. Such products appear useful in the treatment and prevention of diarrheal symptoms regardless of the cause.
Patent NZ-512755-A (NZ)
Title: Method and device for separating and disposing of faeces and urine in urine separation toilets
Inventor: BRAUN ULRICH
IPC: E03D5/014
Filed: 2000-10-04
Abstract: The invention relates to a urine separation toilet. Said toilet can be constructed without a partition between the urine and faecal outlets in such a way that the whole bowl can be cleaned during the flush operation and that the toilet paper in the urine outlet area, together with yellow deposits can be transported to the faecal outlet area. The toilet can nevertheless maintain a water-free disposal of urine.
Patent NZ-518702-A (NZ)
Title: [5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinylamino]acetamide derivatives, process for producing the same, medicinal compositions containing the same and intermediate of these compounds
Inventor: MURATA TERUYA
IPC: A61P37/06
Filed: 2000-11-09
Abstract: A [5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinyl-amino]acetamide derivative of formula (I), wherein R1 is methyl or cyclopropyl. Also disclosed is a process for the preparation of the above compounds, and their use in the manufacture of medicaments for the treatment of immuno inflammatory diseases.
Patent NZ-532274-A (NZ)
Title: Adjuvanted meningococcus compositions
Inventor: O'HAGAN DEREK
IPC: C07H21/02
Filed: 2002-10-03
Abstract: Described is an immunogenic composition that comprises: (a) a Neisserial antigen; (b) a CpG oligonucleotide; and (c) a biodegradable polymer microparticle. Also described is the use of the composition in the manufacture of a medicament for raising an antibody response in a mammal, protecting the mammal against a Neisserial infection and/or disease or other infection and/or disease
Patent NZ-533598-A (NZ)
Title: Peptide, or nucleic acid encoding the same, pharmaceutical composition, or kit that is effective for the treatment of CRF2R modulated disorders such as muscle atrophy or wasting
Inventor: ISFORT ROBERT JOSEPH
IPC: C07K14/575
Filed: 2003-01-16
Abstract: Isolated corticotrophin releasing factor derivatives are described, and nucleic acids encoding the same. These are effective for treating corticotrophin releasing factor 2 receptor modulated disorders such as muscular dystrophy.
Patent NZ-539527-A (NZ)
Title: Controlled releases system containing temozolomide and a biodegradable polymeric material
Inventor: WANG YONGFENG
IPC: A61K31/4188
Filed: 2003-09-29
Abstract: Disclosed is a controlled release system for temozolomide, the system comprising 3-10 wt % of temozolomide and biodegradable polymeric materials. A process of preparing temozolomide controlled release tablets is also disclosed, wherein the process comprises: (a) Dissolving one or more polymeric materials in a solvent to give a solution of polymeric materials; (b) Dispersing temolozomide in or mixing temolozomide with said solution of polymeric materials to produce a mixture of polymeric materials and temolozomide; (c) Spray-drying said mixture of polymeric materials and temolozomide to obtain microspheres; and (d) Tabletting said microspheres to obtain implantable tablets.
Patent NZ-540356-A (NZ)
Title: System and method for protected operating system boot using state validation
Inventor: WILLMAN BRYAN M
IPC: G06F21/14
Filed: 2005-05-27
Abstract: A validation technique for ensuring security of a computer operating system during the loading process is described. A validator 550 evaluates the operating system loader 410 for compliance with a known set of standards and also evaluates the state of the machine 502 on which the operating system is loading. Machine validation involves ensuring that the machine 502 is in a state known to be secure following initial loading of the BIOS, option ROMS and boot sector. If validation of the machine and loader is correct key 204 is provided to the loader which in turn will supply it to the operating system for later use.
Patent NZ-543751-A (NZ)
Title: Compositions and methods for the diagnosis and treatment of tumors of glial origin
Inventor: PHILLIPS HEIDI
IPC: A61K39/395
Filed: 2004-05-21
Abstract: Provided is the use of a binding agent in the preparation of a medicament for therapeutically treating a mammal having a tumor of glial origin comprising cells that express a type B glial tumor antigen. The said binding agent is an antibody that binds to a type B glial tumor antigen with at least 90% amino acid sequence identity to specified polypeptides. Further provided are similar uses wherein the antibody in conjugated to a growth inhibitory agent or a cytotoxic agent, including maytansinoid and calicheamicin, and with or without radiation treatment or a chemotherapeutic agent. Also provided are similar uses with combinations of two or three such antibodies in the preparation of a medicament. Further provided is a method of detecting type B glial tumor using the tumor antigens.
Patent NZ-547007-A (NZ)
Title: Compressible darts and methods for using these darts in subterranean wells
Inventor: SZARKA DAVID D
IPC: E21B33/16
Filed: 2004-11-10
Abstract: A method for activating a plug in a subterranean well bore is disclosed. The method includes the steps of introducing a dart into a receiving configuration within the plug, and applying a differential pressure across the plug to activate the plug. The dart comprises a foam body (13) attached to a mandrel (10).
Patent NZ-548581-A (NZ)
Filed: 2006-07-18
Abstract: A vacuum skin package has a support member, a cheese product loaded onto the support member and a flexible film draped over the cheese product and enclosing the cheese product on the support member. The support member has a range of oxygen transmission of 80 to 500cm3/m2-day-bar and the flexible film has an oxygen transmission rate greater than 500cm3/m2-day-bar (both at 23oC and 0%RH). This is directed to allowing sufficient "breathing" of various types of cheeses without excessively increasing inventory of types of supports and/or films for such cheeses.
Patent NZ-553730-A (NZ)
Title: Chip card for analysing physio-chemical properties of the skin including an environmental sensor
Inventor: LAURENS PAUL
IPC: A61B5/00
Filed: 2005-09-02
Abstract: Disclosed is a chip card (1) for analysing the physicochemical properties of a cutaneous surface. The card comprises: at least one body sensor (2) which can deliver a signal representing a measurement of a physicochemical property of a cutaneous surface; a processing unit (3) used to treat the signal delivered by the body sensor and then to store the said signal in a storage unit (4); an electric power source (5) for supplying the body sensor and the processing unit; and at least one environment sensor (12) which can deliver a signal representing a measurement of a parameter of the external environment.
Patent NZ-561898-A (NZ)
Title: System and method for transporting live aquatic animals
Inventor: TORRING DITTE
IPC: A01K63/02
Filed: 2006-03-22
Abstract: A system for transporting live aquatic animals between shipping points is disclosed. The system includes water filled tanks (300), in a refrigerated marine container (200), and docking stations (100) at the shipping points. During transport, the system uses means (240, 250, 260) for cooling, aerating and circulating the water in the tanks. During docking, the refrigerated marine containers (200) are docked at the docking stations (100), and they use means (120, 130, 140) for providing a life supporting aquatic environment in the tanks (300).
Patent NZ-572060-A (NZ)
Title: Particle monitor with means for purging analysis chamber with heated gas
Inventor: SMITH KENNETH GRAHAM
IPC: G01N15/06
Filed: 2007-04-19
Abstract: A particle monitor (1) for analysing particles including an analysis chamber (4) configured to receive a sample of particles for analysis and analysing means (17) configured to analyse the sample of particles in the analysis chamber (4). Also provided is purging means (8) configured to introduce a pressurised gas into the analysis chamber (4) to purge the sample from the analysis chamber (4) and a heating unit (24) configured to maintain an operating temperature of the analysis chamber (4) and to pre-heat the purging gas used for purging the sample from the analysis chamber (4).
Patent NZ-580619-A (NZ)
Title: Novel benzamide derivatives as modulators of the follicle stimulating hormone
Inventor: BONNET BEATRICE
IPC: C07C233/15
Filed: 2008-03-19
Abstract: Disclosed is a compound having the formula I-A or a pharmaceutically acceptable salt, hydrate or solvate of such compound wherein R1 represents O-C1-6alkyl, O-C2-6alkynyl, O-C2-6alkenyl, O-C3-7cycloalkyl or O-alkylcycloalkyl; or R1 and R2 form a heterocycle; and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of the compound of formula I for preparing a tracer for imaging FSH receptors and for manufacturing a medicament for the treatment or prevention of a condition wichin is affected by the FSH receptor negative allosteric modulators such as uterine fibroids, endometriosis, polycystic ovarian disease, dysfunctional uterine bleeding, hormone-dependent cancer, prostate cancer, uterine cancer, breast cancer and ovarian cancer and osteoporosis, and for contraception.
Patent NZ-581933-A (NZ)
Title: Novel dicarboxylic acid derivatives as s1p1 receptor agonists
Inventor: THENNATI RAJAMANNAR
IPC: C07D271/06
Filed: 2008-06-16
Abstract: Disclosed are dicarboxylic acid derivatives of general formula (I), wherein 1,2,4-oxadiazole group, or enantiomers, diastereomers, hydrates, solvates and pharmaceutically acceptable salts thereof. Such compounds of formula (I) include 1-{ 4-[5-(4-isobutylphenyl)-1,2,4-oxadiazol-3-yl]benzyl} piperidine-4,4-dicarboxylic acid. Processes for preparing the compounds of formula (I) are also disclosed as well as their use for treating transplant rejection, tissue graft rejection, immune disorders, autoimmune disorders, inflammatory and chronic inflammatory conditions, asthma, pollinosis, psoriasis, myocarditis, atopic dermatitis, lymphocytic leukemias, lymphomas, multiple sclerosis, lupus erythematosus, inflammatory bowel diseases, diabetes mellitus, glomerulo-nephritis, atherosclerosis, multi-organ failure, sepsis, pneumonia, optic neuritis, polymyalgia rheumatica, uveitis, vasculitis, osteoarthritis, respiratory distress syndrome, ischemia reperfusion injury, chronic obstructive pulmonary disease, infection associated with inflammation, viral inflammation, influenza, hepatitis, Guillian-Barre syndrome, chronic bronchitis, restenosis, granulomatous disease, sarcoidosis, leprosy, scleroderma, Alzheimer's disease as well as disorders related to impaired vascular integrity, cancers, disregulated angiogenesis or excessive neoangiogenesis.
Patent NZ-585093-A (NZ)
Title: Food material for inhibiting bone resorption
Inventor: SERIZAWA ATSUSHI
IPC: A23K10/28
Filed: 2008-10-28
Abstract: 585093 Provided is a milk protein fraction derived from milk, wherein the milk protein fraction contains proteins having a molecular weight of 12,000 to 16,000 daltons determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), contains 18 to 20wt% of basic amino acids in the constituent amino acid composition, has a basic amino acid/acidic amino acid ratio of 0.7 to 0.9, and has an osteoclastogenesis inhibitory effect.